The management of low-stage non-seminomatous germ cell tumors
نویسندگان
چکیده
The prognosis of patients with stage I non-seminomatous germ cell tumors is in general very good. However, a large number of patients relapse with metastatic disease after orchidectomy Therefore, adjuvant treatment, in the form of either chemotherapy or retroperitoneal dissection is recommended, although active surveillance has been found to be as good a way of treating these patients with overall excellent results.
منابع مشابه
Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature
Very late relapses of germ cell tumors (GCTs) are rare. There are few reports of relapses occurring beyond 20 years of initial treatment. Here we describe a case of a very late relapse of Stage I testicular non-seminomatous germ cell tumor 27 years after orchiectomy. The relapse presented as a retroperitoneal mass in the precaval lymph nodes with negative tumor markers. It was resected and path...
متن کاملClinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
BACKGROUND Testicular cancer management is considered a marvel of modern science with excellent treatment results. Pakistan has a distinct ethnic variation and geographic distribution but data regarding clinical presentation of testicular tumors and their management is under reported. The objective of this study was to determine clinical profile, treatment modalities and survival outcome of tes...
متن کاملDistribution of testicular tumors in Lebanon: a single institution overview.
BACKGROUND Testicular tumors constitute a rare type of cancer affecting adolescents and young adults with recent reports confirming an increase in incidence worldwide. The purpose of this study was to estimate the epidemiological characteristics and histological subtypes of testicular tumors in the Lebanese population according to the WHO classification of testicular and paratesticular tumors. ...
متن کاملActual developments in European regula- tory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe? introduction
non-seminomatous germ cell tumors who undergo post-chemotherapy RPLND for small tumors. J Clin Oncol 2011; 29 (abstr 224). 19. Ehrlich Y, Brames MJ, Beck S et al. Long-term followup of cisplatin combination chemotherapy in patients with disseminated non-seminomatous germ cell tumors: is a post-chemotherapy RPLND needed after complete remission? J Clin Oncol 2010; 28: 531–536. 20. Kollmannsberge...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 6 شماره
صفحات -
تاریخ انتشار 2012